[The effect of kallikrein on sperm motility (author's transl)].
The effect of kallikrein (240 KE/week i.m. or 600 KE/day orally) on the sperm count, sperm motility and morphology was investigated in 27 patients with pathological ejaculate findings. Kallikrein was administered over a period of 9 to 12 weeks. A significant increase in sperm motility was observed in patients with asthenospermia. No influence was noted on the ejaculate findings in patients with oligospermia. Interference between the kallikrein-kinin system and sperm motility is postulated.
D000328:Adult; D006801:Humans; D007248:Infertility, Male / Q000188:drug therapy; D007610:Kallikreins / Q000627:therapeutic use*; D008297:Male; D013081:Sperm Motility / Q000187:drug effects*
D007610:Kallikreins
Spermienmotilität unter Kallikrein